The New Edition of this well-respected text provides current, readable descriptions of a full range of infectious diseases as well as the latest recommendations for therapy. Its clinically oriented, practical format allows busy practitioners to look up any infectious disease topic quickly and efficiently. Plus, it provides a clinical yet authoritative approach to patient care that facilitates rapid decision making. The 2nd Edition includes many new chapters, thoroughly updated drug information, and numerous other revisions to reflect the latest advances in the specialty.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

This edition provides an update of therapies for some infectious diseases. It also suggests alternative approaches for some infectious diseases covered in the previous editions.

The New Edition of this well-respected text provides current, readable descriptions of a full range of infectious diseases as well as the latest recommendations for therapy. Its clinically oriented, practical format allows busy practitioners to look up any infectious disease topic quickly and efficiently. Plus, it provides a clinical yet authoritative approach to patient care that facilitates rapid decision making. The 2nd Edition includes many new chapters, thoroughly updated drug information, and numerous other revisions to reflect the latest advances in the specialty.

Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.